| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bbea6741205e21ceaddc9d0f4366d47b |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 |
| filingDate |
2001-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b967532297f62ea3045e4d273c4568ff |
| publicationDate |
2011-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RO-123165-B1 |
| titleOfInvention |
PHARMACEUTICAL COMPOSITION OF ANTIDIABETIC ADJUVANT AND HYPOOGLYCAMIC |
| abstract |
The invention relates to an antidiabetic and hypoglycemic adjuvant. The adjuvant according to the invention comprises zimazase, secretin, thiamine and fructose in a ratio of 1: 1: 10: 200. |
| priorityDate |
2001-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |